251 related articles for article (PubMed ID: 17354201)
1. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].
Pisarek M; Baczyk M; Gryczyńska M; Sowiński J
Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201
[TBL] [Abstract][Full Text] [Related]
2. [Autoimmunization and multinodular large toxic goiter therapy using repeated doses of 131I].
Pisarek M; Baczyk M; Gryczyńska M; Pietz L; Ziemnicka K; Sowiński J
Pol Arch Med Wewn; 2006 Jun; 115(6):545-50. PubMed ID: 17263226
[TBL] [Abstract][Full Text] [Related]
3. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
6. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
7. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
9. Therapy of large multinodular goitre using repeated doses of radioiodine.
Baczyk M; Pisarek M; Czepczyński R; Ziemnicka K; Gryczyńska M; Pietz L; Sowiński J
Nucl Med Commun; 2009 Mar; 30(3):226-31. PubMed ID: 19262285
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
[TBL] [Abstract][Full Text] [Related]
11. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.
Cohen O; Ilany J; Hoffman C; Olchovsky D; Dabhi S; Karasik A; Goshen E; Rotenberg G; Zwas ST
Eur J Endocrinol; 2006 Feb; 154(2):243-52. PubMed ID: 16452537
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine therapy for multinodular toxic goiter.
Nygaard B; Hegedüs L; Ulriksen P; Nielsen KG; Hansen JM
Arch Intern Med; 1999 Jun; 159(12):1364-8. PubMed ID: 10386513
[TBL] [Abstract][Full Text] [Related]
13. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial.
Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Grupe P; Hegedüs L
Arch Intern Med; 2006 Jul; 166(14):1476-82. PubMed ID: 16864757
[TBL] [Abstract][Full Text] [Related]
14. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
15. Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter.
Riguetto CM; Miguel VP; Pavin EJ; Amorim BJ; Ramos CD; Zantut-Wittmann DE
Nucl Med Commun; 2020 Aug; 41(8):727-732. PubMed ID: 32427701
[TBL] [Abstract][Full Text] [Related]
16. [Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery].
Dietlein M; Dederichs B; Kobe C; Theissen P; Schmidt M; Schicha H
Nuklearmedizin; 2006; 45(1):21-34; quiz N1-2. PubMed ID: 16493511
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
[TBL] [Abstract][Full Text] [Related]
18. Combination of Ultrasound-Guided Percutaneous Microwave Ablation and Radioiodine Therapy in Benign Thyroid Disease: A 3-Month Follow-Up Study.
Korkusuz H; Happel C; Koch DA; Gruenwald F
Rofo; 2016 Jan; 188(1):60-8. PubMed ID: 26566268
[TBL] [Abstract][Full Text] [Related]
19. Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters.
Duick DS; Baskin HJ
Endocr Pract; 2003; 9(3):204-9. PubMed ID: 12917062
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine for nontoxic multinodular goiter.
Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P
Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
